McRae Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Hold
5,035
0.08% 77
2026
Q1
$356K Hold
5,035
0.07% 86
2025
Q4
$397K Hold
5,035
0.08% 80
2025
Q3
$415K Hold
5,035
0.08% 82
2025
Q2
$405K Hold
5,035
0.08% 80
2025
Q1
$404K Buy
5,035
+121
+2% +$10.1K 0.09% 72
2024
Q4
$402K Buy
4,914
+79
+2% +$6.57K 0.08% 72
2024
Q3
$399K Sell
4,835
-532
-10% -$39.7K 0.08% 72
2024
Q2
$377K Hold
5,367
0.09% 72
2024
Q1
$398K Sell
5,367
-20
-0.4% -$1.39K 0.09% 74
2023
Q4
$356K Sell
5,387
-413
-7% -$25.8K 0.09% 73
2023
Q3
$365K Buy
5,800
+965
+20% +$60.1K 0.11% 72
2023
Q2
$273K Buy
+4,835
New +$268K 0.08% 80

Other funds holding MET

McRae Capital Management's MET Position: Q2 2026 in Review

McRae Capital Management held its MetLife (MET) position steady in Q2 2026 at 5,035 shares worth $426K. The position accounts for 0.08% of the portfolio, ranked #77.

McRae Capital Management first reported a position in MET in Q2 2023 and has held it in 13 quarters since. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • McRae Capital Management held 5,035 shares of MetLife worth $426K as of Q2 2026.
  • McRae Capital Management left its MetLife share count unchanged in Q2 2026.
  • MetLife made up 0.08% of McRae Capital Management's portfolio in Q2 2026, its #77 holding.
  • McRae Capital Management first reported a position in MetLife in Q2 2023 and has held it in 13 quarters since.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.